
|Articles|July 1, 2003
VISX gets OK from FDA; investors block takeover
Santa Clara, CA-VISX Inc. is celebrating the FDA approval of its CustomVue laser-vision correction procedure, as its board survived an attempt to dethrone one member in a takeover plan by financier Carl C. Icahn.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Phase 3 NORTHSTAR Trial Launches for Gildeuretinol in Stargardt Disease
2
Rising Star: Introducing Viha Vig, MBChB
3
Self-Screening for Ocular Surface Malignancies Using a Smartphone
4
Everest Medicines acquires Greater China rights to Aceclidine Presbyopia Eye Drop (VIZZ)
5





















